Flow-mediated outward remodeling (FMR) is involved in postischemic revascularization. Angiotensin II type 2 receptor (AT2R), through activation of T-cell-mediated IL-17 production, and estrogens are involved in FMR. Thus, we investigated the interplay between estrogens and AT2R in FMR using a model of ligation of feed arteries supplying collateral pathways in mouse mesenteric arteries in vivo. Arteries were collected after 2 (inflammatory phase), 4 (diameter expansion phase), and 7 days (remodeling completed). We used AT2R+/+ and AT2R−/− ovariectomized (OVX) female mice treated or not with 17-beta-estradiol (E2). Seven days after ligation, arterial diameter was larger in high flow (HF) compared to normal flow (NF) arteries. FMR was absent in OVX mice and restored by E2. AT2R gene expression was higher in HF than in NF arteries only in E2-treated OVX AT2R+/+ mice. CD11b and TNF alpha levels (inflammatory phase), MMP2 and TIMP1 (extracellular matrix digestion), and NOS3 (diameter expansion phase) expression levels were higher in HF than in NF arteries only in E2-treated AT2R+/+ mice, not in the other groups. Thus, E2 is necessary for AT2R-dependent diameter expansion, possibly through activation of T-cell AT2R, in arteries submitted chronically to high blood flow.

1.
Carmeliet
P
.
Mechanisms of angiogenesis and arteriogenesis
.
Nat Med
.
2000 Apr
;
6
(
4
):
389
95
. .
2.
Grundmann
S
,
Piek
JJ
,
Pasterkamp
G
,
Hoefer
IE
.
Arteriogenesis: basic mechanisms and therapeutic stimulation
.
Eur J Clin Invest
.
2007 Oct
;
37
(
10
):
755
66
. .
3.
Schaper
W
.
Collateral circulation: past and present
.
Basic Res Cardiol
.
2009 Jan
;
104
(
1
):
5
21
. .
4.
Silvestre
JS
,
Smadja
DM
,
Lévy
BI
.
Postischemic revascularization: from cellular and molecular mechanisms to clinical applications
.
Physiol Rev
.
2013 Oct
;
93
(
4
):
1743
802
. .
5.
Pourageaud
F
,
De Mey
JG
.
Structural properties of rat mesenteric small arteries after 4-wk exposure to elevated or reduced blood flow
.
Am J Physiol
.
1997 Oct
;
273
(
4 Pt 2
):
H1699
706
. .
6.
Pourageaud
F
,
De Mey
JG
.
Vasomotor responses in chronically hyperperfused and hypoperfused rat mesenteric arteries
.
Am J Physiol
.
1998 Apr
;
274
(
4 Pt 2
):
H1301
7
. .
7.
Dumont
O
,
Loufrani
L
,
Henrion
D
.
Key role of the NO-pathway and matrix metalloprotease-9 in high blood flow-induced remodeling of rat resistance arteries
.
Arterioscler Thromb Vasc Biol
.
2007 Feb
;
27
(
2
):
317
24
. .
8.
Bakker
EN
,
Matlung
HL
,
Bonta
P
,
de Vries
CJ
,
van Rooijen
N
,
Vanbavel
E
.
Blood flow-dependent arterial remodelling is facilitated by inflammation but directed by vascular tone
.
Cardiovasc Res
.
2008 May 1
;
78
(
2
):
341
8
. .
9.
Freidja
ML
,
Toutain
B
,
Caillon
A
,
Desquiret
V
,
Lambert
D
,
Loufrani
L
, et al.
Heme oxygenase 1 is differentially involved in blood flow-dependent arterial remodeling: role of inflammation, oxidative stress, and nitric oxide
.
Hypertension
.
2011 Aug
;
58
(
2
):
225
31
. .
10.
Caillon
A
,
Grenier
C
,
Grimaud
L
,
Vessieres
E
,
Guihot
AL
,
Blanchard
S
, et al.
The angiotensin II type 2 receptor activates flow-mediated outward remodelling through T cells-dependent interleukin-17 production
.
Cardiovasc Res
.
2016 Oct
;
112
(
1
):
515
25
. .
11.
Stabile
E
,
Kinnaird
T
,
la Sala
A
,
Hanson
SK
,
Watkins
C
,
Campia
U
, et al.
CD8+ T lymphocytes regulate the arteriogenic response to ischemia by infiltrating the site of collateral vessel development and recruiting CD4+ mononuclear cells through the expression of interleukin-16
.
Circulation
.
2006 Jan 3
;
113
(
1
):
118
24
. .
12.
van Weel
V
,
Seghers
L
,
de Vries
MR
,
Kuiper
EJ
,
Schlingemann
RO
,
Bajema
IM
, et al.
Expression of vascular endothelial growth factor, stromal cell-derived factor-1, and CXCR4 in human limb muscle with acute and chronic ischemia
.
Arterioscler Thromb Vasc Biol
.
2007 Jun
;
27
(
6
):
1426
32
. .
13.
van Weel
V
,
Toes
RE
,
Seghers
L
,
Deckers
MM
,
de Vries
MR
,
Eilers
PH
, et al.
Natural killer cells and CD4+ T-cells modulate collateral artery development
.
Arterioscler Thromb Vasc Biol
.
2007 Nov
;
27
(
11
):
2310
8
. .
14.
Vukelic
S
,
Griendling
KK
.
Angiotensin II, from vasoconstrictor to growth factor: a paradigm shift
.
Circ Res
.
2014 Feb 28
;
114
(
5
):
754
7
. .
15.
Hoch
NE
,
Guzik
TJ
,
Chen
W
,
Deans
T
,
Maalouf
SA
,
Gratze
P
, et al.
Regulation of T-cell function by endogenously produced angiotensin II
.
Am J Physiol Regul Integr Comp Physiol
.
2009 Feb
;
296
(
2
):
R208
16
. .
16.
Tarhouni
K
,
Freidja
ML
,
Guihot
AL
,
Vessieres
E
,
Grimaud
L
,
Toutain
B
, et al.
Role of estrogens and age in flow-mediated outward remodeling of rat mesenteric resistance arteries
.
Am J Physiol Heart Circ Physiol
.
2014 Aug 15
;
307
(
4
):
H504
14
. .
17.
Tarhouni
K
,
Guihot
AL
,
Vessières
E
,
Toutain
B
,
Procaccio
V
,
Grimaud
L
, et al.
Determinants of flow-mediated outward remodeling in female rodents: respective roles of age, estrogens, and timing
.
Arterioscler Thromb Vasc Biol
.
2014 Jun
;
34
(
6
):
1281
9
. .
18.
Tarhouni
K
,
Guihot
AL
,
Freidja
ML
,
Toutain
B
,
Henrion
B
,
Baufreton
C
, et al.
Key role of estrogens and endothelial estrogen receptor α in blood flow-mediated remodeling of resistance arteries
.
Arterioscler Thromb Vasc Biol
.
2013 Mar
;
33
(
3
):
605
11
. .
19.
Armando
I
,
Jezova
M
,
Juorio
AV
,
Terrón
JA
,
Falcón-Neri
A
,
Semino-Mora
C
, et al.
Estrogen upregulates renal angiotensin II AT(2) receptors
.
Am J Physiol Renal Physiol
.
2002 Nov
;
283
(
5
):
F934
43
. .
20.
Sampson
AK
,
Moritz
KM
,
Denton
KM
.
Postnatal ontogeny of angiotensin receptors and ACE2 in male and female rats
.
Gend Med
.
2012 Feb
;
9
(
1
):
21
32
. .
21.
Bukowska
A
,
Spiller
L
,
Wolke
C
,
Lendeckel
U
,
Weinert
S
,
Hoffmann
J
, et al.
Protective regulation of the ACE2/ACE gene expression by estrogen in human atrial tissue from elderly men
.
Exp Biol Med
.
2017 Aug
;
242
(
14
):
1412
23
. .
22.
Loufrani
L
,
Li
Z
,
Lévy
BI
,
Paulin
D
,
Henrion
D
.
Excessive microvascular adaptation to changes in blood flow in mice lacking gene encoding for desmin
.
Arterioscler Thromb Vasc Biol
.
2002
;
22
(
10
):
1579
84
. .
23.
Bolla
M
,
Matrougui
K
,
Loufrani
L
,
Maclouf
J
,
Levy
B
,
Levy-Toledano
S
, et al.
p38 mitogen-activated protein kinase activation is required for thromboxane- induced contraction in perfused and pressurized rat mesenteric resistance arteries
.
J Vasc Res
.
2002 Jul–Aug
;
39
(
4
):
353
60
. .
24.
Loufrani
L
,
Matrougui
K
,
Li
Z
,
Levy
BI
,
Lacolley
P
,
Paulin
D
, et al.
Selective microvascular dysfunction in mice lacking the gene encoding for desmin
.
Faseb J
.
2002 Jan
;
16
(
1
):
117
9
. .
25.
Loufrani
L
,
Matrougui
K
,
Gorny
D
,
Duriez
M
,
Blanc
I
,
Lévy
BI
, et al.
Flow (shear stress)-induced endothelium-dependent dilation is altered in mice lacking the gene encoding for dystrophin
.
Circulation
.
2001 Feb 13
;
103
(
6
):
864
70
. .
26.
Shen
M
,
Morton
J
,
Davidge
ST
,
Kassiri
Z
.
Loss of smooth muscle cell disintegrin and metalloproteinase 17 transiently suppresses angiotensin II-induced hypertension and end-organ damage
.
J Mol Cell Cardiol
.
2017 Feb
;
103
:
11
21
. .
27.
Cousin
M
,
Custaud
MA
,
Baron-Menguy
C
,
Toutain
B
,
Dumont
O
,
Guihot
AL
, et al.
Role of angiotensin II in the remodeling induced by a chronic increase in flow in rat mesenteric resistance arteries
.
Hypertension
.
2010 Jan
;
55
(
1
):
109
15
. .
28.
Freidja
ML
,
Tarhouni
K
,
Toutain
B
,
Fassot
C
,
Loufrani
L
,
Henrion
D
.
The AGE-breaker ALT-711 restores high blood flow-dependent remodeling in mesenteric resistance arteries in a rat model of type 2 diabetes
.
Diabetes
.
2012 Jun
;
61
(
6
):
1562
72
. .
29.
Arnal
JF
,
Lenfant
F
,
Metivier
R
,
Flouriot
G
,
Henrion
D
,
Adlanmerini
M
, et al.
Membrane and nuclear estrogen receptor alpha actions: from tissue specificity to medical implications
.
Physiol Rev
.
2017 Jul 1
;
97
(
3
):
1045
87
. .
30.
Arnal
JF
,
Fontaine
C
,
Billon-Galés
A
,
Favre
J
,
Laurell
H
,
Lenfant
F
, et al.
Estrogen receptors and endothelium
.
Arterioscler Thromb Vasc Biol
.
2010 Aug
;
30
(
8
):
1506
12
. .
31.
Kadel
S
,
Kovats
S
.
Sex hormones regulate innate immune cells and promote sex differences in respiratory virus infection
.
Front Immunol
.
2018
;
9
:
1653
. .
32.
Carey
LC
,
Rose
JC
.
The midgestational maternal blood pressure decline is absent in mice lacking expression of the angiotensin II AT2 receptor
.
J Renin Angiotensin Aldosterone Syst
.
2011 Mar
;
12
(
1
):
29
35
. .
33.
Chen
K
,
Merrill
DC
,
Rose
JC
.
The importance of angiotensin II subtype receptors for blood pressure control during mouse pregnancy
.
Reprod Sci
.
2007 Oct
;
14
(
7
):
694
704
. .
34.
Gwathmey
TM
,
Alzayadneh
EM
,
Pendergrass
KD
,
Chappell
MC
.
Novel roles of nuclear angiotensin receptors and signaling mechanisms
.
Am J Physiol Regul Integr Comp Physiol
.
2012 Mar 1
;
302
(
5
):
R518
30
. .
35.
Widdop
RE
,
Matrougui
K
,
Levy
BI
,
Henrion
D
.
AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade
.
Hypertension
.
2002 Oct
;
40
(
4
):
516
20
. .
36.
Pinaud
F
,
Bocquet
A
,
Dumont
O
,
Retailleau
K
,
Baufreton
C
,
Andriantsitohaina
R
, et al.
Paradoxical role of angiotensin II type 2 receptors in resistance arteries of old rats
.
Hypertension
.
2007 Jul
;
50
(
1
):
96
102
. .
37.
Castineiras-Landeira
MI
,
Rodino-Janeiro
BK
,
Paradela-Dobarro
B
,
Batista-Oliveira
AL
,
Raposeiras-Roubin
S
,
Gonzalez-Peteiro
M
, et al.
Change of concept about the regulation of angiotensin II-induced monocyte chemoattractant protein-1 production in human endothelial cells
.
Vascul Pharmacol
.
2016 May
;
80
:
20
34
. .
[PubMed]
.
38.
Sader
MA
,
Celermajer
DS
.
Endothelial function, vascular reactivity and gender differences in the cardiovascular system
.
Cardiovasc Res
.
2002 Feb 15
;
53
(
3
):
597
604
. .
39.
Cockell
AP
,
Poston
L
.
Isolated mesenteric arteries from pregnant rats show enhanced flow-mediated relaxation but normal myogenic tone
.
J Physiol
.
1996 Sep 1
;
495
(
Pt 2
):
545
51
. .
40.
Huang
A
,
Sun
D
,
Koller
A
,
Kaley
G
.
Gender difference in flow-induced dilation and regulation of shear stress: role of estrogen and nitric oxide
.
Am J Physiol
.
1998 Nov
;
275
(
5 Pt 2
):
R1571
7
. .
41.
LeBlanc
AJ
,
Reyes
R
,
Kang
LS
,
Dailey
RA
,
Stallone
JN
,
Moningka
NC
, et al.
Estrogen replacement restores flow-induced vasodilation in coronary arterioles of aged and ovariectomized rats
.
Am J Physiol Regul Integr Comp Physiol
.
2009 Dec
;
297
(
6
):
R1713
23
. .
42.
Oliveira
V
,
Akamine
EH
,
Carvalho
MH
,
Michelini
LC
,
Fortes
ZB
,
Cunha
TS
, et al.
Influence of aerobic training on the reduced vasoconstriction to angiotensin II in rats exposed to intrauterine growth restriction: possible role of oxidative stress and AT2 receptor of angiotensin II
.
PloS One
.
2014
;
9
(
11
):
e113035
. .
43.
Tuttle
JL
,
Hahn
TL
,
Sanders
BM
,
Witzmann
FA
,
Miller
SJ
,
Dalsing
MC
, et al.
Impaired collateral development in mature rats
.
Am J Physiol Heart Circ Physiol
.
2002 Jul
;
283
(
1
):
H146
55
. .
44.
Dumont
O
,
Pinaud
F
,
Guihot
AL
,
Baufreton
C
,
Loufrani
L
,
Henrion
D
.
Alteration in flow (shear stress)-induced remodelling in rat resistance arteries with aging: improvement by a treatment with hydralazine
.
Cardiovasc Res
.
2008 Feb 1
;
77
(
3
):
600
8
. .
45.
Belin de Chantemele
EJ
,
Vessieres
E
,
Guihot
AL
,
Toutain
B
,
Maquignau
M
,
Loufrani
L
, et al.
Type 2 diabetes severely impairs structural and functional adaptation of rat resistance arteries to chronic changes in blood flow
.
Cardiovasc Res
.
2009 Mar 1
;
81
(
4
):
788
96
. .
[PubMed]
.
46.
Freidja
ML
,
Vessières
E
,
Toutain
B
,
Guihot
AL
,
Custaud
MA
,
Loufrani
L
, et al.
AGEs breaking and antioxidant treatment improves endothelium-dependent dilation without effect on flow-mediated remodeling of resistance arteries in old Zucker diabetic rats
.
Cardiovasc Diabetol
.
2014
;
13
:
55
. .
47.
Foulquier
S
,
Steckelings
UM
,
Unger
T
.
Perspective: a tale of two receptors
.
Nature
.
2013 Jan 31
;
493
(
7434
):
S9
. .
48.
Hein
L
,
Barsh
GS
,
Pratt
RE
,
Dzau
VJ
,
Kobilka
BK
.
Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice
.
Nature
.
1995 Oct 26
;
377
(
6551
):
744
7
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.